|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 15th Street, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Deerfield |
State | IL |
Zip Code | 60015 |
Country | USA |
|
5. Senate ID# 5610-12
|
||||||||
|
6. House ID# 325030000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Joseph Schwan |
Date | 10/20/2015 1:28:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Report language for Labor HHS and VA-Milcon Annual Appropriations Bills
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Coin |
|
|
|
Jack |
Maniko |
|
|
|
Kelli |
Lester |
|
|
|
Crystal |
Riley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation to cut Medicare Part B Drug Reimbursement, Medicare Part B DME Competitive Bidding Program.
Raise awareness with legislators about the barriers to and the importance of protecting access for home dialysis.
H.R. 3306: Telehealth Enhancement Act of 2013. The Chronic Kidney Disease Improvement in Research and Treatment Act is S.598 and H.R.1130
H.R.2948 Medicare Tele-health Parity Act of 2015
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jack |
Maniko |
|
|
|
Kelli |
Lester |
|
|
|
Mark |
Coin |
|
|
|
Crystal |
Riley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
340B Drug Discount Program; FDA Regulatory Environment.
Raise awareness with legislators about the benefits of home dialysis. Disease registry for Mutifocal Motor Neuropathy at NIH.
21st Century Cures Legislation-Healthier Americas Initiative
Raise Awareness with legislators about survey and certification issues as it relates to home dialysis.
Telehealth Modernization Act of 2015- Calls for states to authorize health care professionals to deliver health care to individuals through telehealth and consider adopting various conditions under which a health care professional delivering care through telehealth should perform such services
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jack |
Maniko |
|
|
|
Kelli |
Lester |
|
|
|
Mark |
Coin |
|
|
|
Joseph |
Schwan |
|
|
|
Crystal |
Riley |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Device Tax Legislation.
H.Con.Res. 25 S.Con. Res. Budget Resolutions
Innovation Promotion Act of 2015 discussion draft
International Tax Reform
HR 880, the American Research and Competitiveness Act, and S. 537, the COMPETE Act, as they relate to the R&D tax credit. HR 2510, to make permanent bonus depreciation. HR 1430, to make permanent the CFC look through rule. S. 1946, the Tax Relief Extension Act, as it relates to the R&D credit, bonus depreciation, and the CFC look-through rule. HR 160, the Protect Medical Innovation Act, and S. 149, the Medical Device Access and Innovation Act, as they relate to repeal of the medical device excise tax. Budget reconciliation legislation, as it relates to the repeal of the medical device tax. Issues related to corporate tax reform and the taxation of U.S. multinational corporations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joseph |
Schwan |
|
|
|
Jack |
Maniko |
|
|
|
Maria Gabrielle |
Buccilli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 9 - The Innovation Act
S. 1137 - The PATENT Act (The Protecting American Talent and Entrepreneurship Act)
S. 632 - The STRONG Act (The Support Technology and Research for Our Nations Growth Act)
H.R. 1832 - The Innovation Protection Act
H.R. 2045 - The TROL Act (The Targeting Rogue and Opaque Letters Act)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joseph |
Schwan |
|
|
|
Maria Gabrielle |
Buccilli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
H.R. 1295 Trade Preferences Extension Act of 2015. Support opening international markets by supporting the Trade Promotion Authority and the Trans Pacific Partnership agreement.
Trans-Pacific Partnership Agreement
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maria Gabrielle |
Buccilli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |